Real Estate Contracts & Agreements in the Biotechnology Industry

2,509 Contracts & Agreements

Browse by Subcategory

Lease Agreements (2,497 contracts from 497 companies)
Mortgage Agreements (12 | 6)

Browse by Company

89bio, Inc. (3 contracts)
ACADIA PHARMACEUTICALS INC (10)
ACCELERON PHARMA INC (2)
Achaogen, Inc. (7)
ACHIEVE LIFE SCIENCES, INC. (9)
Acorda Therapeutics (4)
Actinium Pharmaceuticals, Inc. (2)
Acumen Pharmaceuticals, Inc. (2)
Adamas Pharmaceuticals Inc (9)
Adaptimmune Therapeutics PLC (5)
Adhera Therapeutics, Inc. (11)
ADiTx Therapeutics, Inc. (1)
ADMA BIOLOGICS, INC. (3)
ADURO BIOTECH, INC. (4)
Advaxis, Inc. (2)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (4)
Aerovate Therapeutics, Inc. (4)
AGENUS INC (23)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (13)
AILERON THERAPEUTICS INC (4)
Aimmune Therapeutics, Inc. (7)
AKCEA THERAPEUTICS, INC. (6)
Akebia Therapeutics, Inc. (9)
Akero Therapeutics, Inc. (1)
Akouos, Inc. (2)
ALBIREO PHARMA, INC. (9)
Aldeyra Therapeutics, Inc. (8)
Alector, Inc. (2)
Alexion Pharmaceuticals (3)
Aligos Therapeutics, Inc. (2)
Alkermes plc. (6)
Allakos Inc. (3)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (2)
Allogene Therapeutics, Inc. (7)
Allovir, Inc. (5)
ALNYLAM PHARMACEUTICALS, INC. (14)
Alpha Healthcare Acquisition Corp. (5)
ALPINE IMMUNE SCIENCES, INC. (5)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (9)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (11)
ANAPTYSBIO INC (6)
ANAVEX LIFE SCIENCES CORP. (2)
Anika Therapeutics (11)
Annexon, Inc. (2)
Apellis Pharmaceuticals, Inc. (9)
APPLIED GENETIC TECHNOLOGIES CORP (6)
Applied Molecular Transport Inc. (4)
Aptevo Therapeutics Inc. (3)
Aptinyx Inc. (1)
AquaBounty Technologies, Inc. (3)
AQUINOX PHARMACEUTICALS, INC (10)
Aravive, Inc. (4)
Arbutus Biopharma Corp (3)
ARCA biopharma, Inc. (15)
Arcellx, Inc. (1)
Arcturus Therapeutics Holdings Inc. (4)
Arcus Biosciences, Inc. (3)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (8)
ARENA PHARMACEUTICALS INC (5)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (9)
Arsanis, Inc. (7)
Artiva Biotherapeutics, Inc. (2)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (7)
Athenex, Inc. (1)
ATOSSA GENETICS INC (8)
Atreca, Inc. (6)
aTYR PHARMA INC (6)
Aura Biosciences, Inc. (1)
Aurinia Pharmaceuticals Inc. (3)
AVEO PHARMACEUTICALS INC (11)
Avidity Biosciences, Inc. (4)
Avita Therapeutics, Inc. (5)
AVROBIO, Inc. (1)
Axcella Health Inc. (3)
Ayala Pharmaceuticals, Inc. (1)
BCTG Acquisition Corp. (1)
Beam Therapeutics Inc. (5)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (11)
BICYCLE THERAPEUTICS Ltd (1)
Big Cypress Acquisition Corp. (2)
BIO-PATH HOLDINGS INC (2)
bioAffinity Technologies, Inc. (2)
BioAtla, Inc. (2)
BioCardia, Inc. (7)
BIOCEPT INC (8)
BIOCRYST PHARMACEUTICALS INC (2)
Biogen Inc. (11)
BIOMARIN PHARMACEUTICAL INC (3)
Biomea Fusion, Inc. (2)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (9)
Biostage, Inc. (1)
BIOTIME INC (7)
BioXcel Therapeutics, Inc. (2)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (1)
bluebird bio, Inc. (11)
Blueprint Medicines Corp (6)
Bolt Biotherapeutics, Inc. (4)
BridgeBio Pharma, Inc. (1)
C4 Therapeutics, Inc. (2)
Cabaletta Bio, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (8)
Calithera Biosciences, Inc. (4)
Calyxt, Inc. (1)
CANCER GENETICS, INC (5)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (12)
Capstone Therapeutics Corp. (1)
CareDx, Inc. (5)
Caribou Biosciences, Inc. (3)
CASI Pharmaceuticals, Inc. (3)
CASTLE BIOSCIENCES INC (18)
Castle Creek Biosciences, Inc. (3)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (5)
CATALYST PHARMACEUTICALS, INC. (7)
Celcuity Inc. (6)
Celldex Therapeutics, Inc. (13)
Cellectar Biosciences, Inc. (3)
Cellular Biomedicine Group, Inc. (6)
Celsion CORP (3)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition Corp. (9)
Chelsea Worldwide Inc. (2)
ChemoCentryx, Inc. (6)
CHIMERIX INC (11)
Cidara Therapeutics, Inc. (8)
CM Life Sciences III Inc. (2)
Codiak BioSciences, Inc. (3)
Coherus BioSciences, Inc. (2)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (7)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (2)
Constellation Alpha Capital Corp. (8)
CONSTELLATION PHARMACEUTICALS INC (4)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (7)
Cortexyme, Inc. (2)
Corvus Pharmaceuticals, Inc. (5)
Crinetics Pharmaceuticals, Inc. (2)
CRISPR Therapeutics AG (7)
CTD HOLDINGS INC (2)
CTI BIOPHARMA CORP (4)
Cullinan Oncology, LLC (1)
CURIS INC (4)
Cyclacel Pharmaceuticals, Inc. (6)
Cyclerion Therapeutics, Inc. (3)
Cytokinetics, Incorporated (9)
CytomX Therapeutics, Inc. (2)
CYTORI THERAPEUTICS, INC. (7)
CYTRX CORP (7)
Day One Biopharmaceuticals Holding Co LLC (2)
DBV Technologies S.A. (2)
Decibel Therapeutics, Inc. (2)
Deciphera Pharmaceuticals, Inc. (4)
Denali Therapeutics Inc. (2)
Dermavant Sciences Ltd (3)
Dermira, Inc. (4)
Design Therapeutics, Inc. (2)
DiaMedica Therapeutics Inc. (6)
Dicerna Pharmaceuticals Inc (5)
Diffusion Pharmaceuticals Inc. (2)
DYADIC INTERNATIONAL INC (5)
Dynamics Special Purpose Corp. (7)
DYNAVAX TECHNOLOGIES CORP (9)
Dyne Therapeutics, Inc. (5)
Eagle Pharmaceuticals, Inc. (2)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (1)
Eidos Therapeutics, Inc. (3)
Eiger BioPharmaceuticals, Inc. (5)
Emerald Bioscience, Inc. (4)
Emergent BioSolutions Inc. (7)
Enanta Pharmaceuticals, Inc. (6)
Enochian Biosciences Inc (4)
Entrada Therapeutics, Inc. (2)
Environmental Impact Acquisition Corp (4)
ENZON PHARMACEUTICALS, INC. (2)
Epizyme, Inc. (7)
Equillium, Inc. (1)
Erasca, Inc. (2)
Esperion Therapeutics, Inc. (7)
Evelo Biosciences, Inc. (3)
EXACT SCIENCES CORP (13)
Exelixis (35)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (9)
FENNEC PHARMACEUTICALS INC. (2)
Fibrocell Science, Inc. (3)
FIBROGEN INC (1)
Finch Therapeutics Group, Inc. (4)
FIVE PRIME THERAPEUTICS INC (5)
Flex Pharma, Inc. (2)
Flexion Therapeutics Inc (10)
FLUOROPHARMA MEDICAL, INC. (2)
Foghorn Therapeutics Inc. (3)
Forma Therapeutics Holdings, Inc., (4)
Forty Seven, Inc. (3)
Frequency Therapeutics, Inc. (7)
FS Development Corp. (1)
Fusion Pharmaceuticals Inc. (4)
G1 Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (1)
Galecto Inc. (2)
Gemphire Therapeutics Inc. (6)
Gene Biotherapeutics, Inc. (3)
GENELUX CORP (4)
Generation Bio Co. (3)
GENOCEA BIOSCIENCES, INC. (5)
GeoVax Labs, Inc. (5)
GERON CORP (9)
Global Blood Therapeutics, Inc. (5)
GLYCOMIMETICS INC (5)
GOLDENWELL BIOTECH, INC. (1)
Gossamer Bio, Inc. (3)
Grail, Inc. (3)
Graphite Bio, Inc. (5)
Gritstone Oncology, Inc. (8)
GT Biopharma, Inc. (2)
GTX INC (8)
GX Acquisition Corp. (3)
HALOZYME THERAPEUTICS INC (8)
HARBOR DIVERSIFIED, INC. (1)
Harpoon Therapeutics, Inc. (3)
HCW Biologics Inc. (1)
HEAT BIOLOGICS, INC. (8)
HedgePath Pharmaceuticals, Inc. (1)
HEMISPHERX BIOPHARMA INC (5)
HERON THERAPEUTICS, INC. (9)
HISTOGENICS CORP (8)
Homology Medicines, Inc. (4)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (2)
iBio, Inc. (2)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (5)
IDERA PHARMACEUTICALS, INC. (4)
IGM Biosciences, Inc. (2)
IMMUNE PHARMACEUTICALS INC (1)
Immuneering Corp (1)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (13)
IMMUNOMEDICS INC (1)
IMPEL NEUROPHARMA INC (1)
IN8BIO, INC. (5)
Incyte (5)
INFINITY PHARMACEUTICALS, INC. (14)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (2)
InMed Pharmaceuticals Inc. (1)
Inmune Bio, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (4)
Inozyme Pharma, Inc. (2)
INSMED Inc (12)
Intellia Therapeutics, Inc. (6)
INTERCEPT PHARMACEUTICALS, INC. (11)
International Stem Cell CORP (6)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (4)
IOVANCE BIOTHERAPEUTICS, INC. (11)
IRONWOOD PHARMACEUTICALS INC (16)
Isoray, Inc. (4)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (4)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (6)
Karuna Therapeutics, Inc. (2)
Karyopharm Therapeutics Inc. (6)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (2)
Kindred Biosciences, Inc. (4)
Kiniksa Pharmaceuticals, Ltd. (5)
Kinnate Biopharma Inc. (2)
Kiromic Biopharma, Inc. (6)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
Kodiak Sciences Inc. (1)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (17)
Kura Oncology, Inc. (15)
Kymera Therapeutics, Inc. (1)
LEAP THERAPEUTICS, INC. (9)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (5)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (7)
Locust Walk Acquisition Corp. (2)
LogicBio Therapeutics, Inc. (1)
LONGEVERON LLC (1)
Lyell Immunopharma, Inc. (5)
MACROGENICS INC (12)
MADRIGAL PHARMACEUTICALS, INC. (6)
Magenta Therapeutics, Inc. (4)
MANNKIND CORP (3)
MARIZYME INC (2)
MATEON THERAPEUTICS INC (8)
Matinas BioPharma Holdings, Inc. (2)
MAXCYTE, INC. (9)
MEDICINOVA INC (2)
MeiraGTx Holdings plc (9)
MERRIMACK PHARMACEUTICALS INC (12)
Mersana Therapeutics, Inc. (4)
Merus N.V. (3)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (7)
MiMedx Group, Inc. (11)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (13)
Mirati Therapeutics, Inc. (9)
Mirum Pharmaceuticals, Inc. (4)
Moderna, Inc. (2)
Molecular Templates, Inc. (12)
Moleculin Biotech, Inc. (2)
Momenta Pharmaceuticals, Inc. (16)
Monte Rosa Therapeutics, Inc. (3)
Morphic Holding, Inc. (3)
MUSTANG BIO, INC. (5)
Myriad Genetics, Inc. (13)
NANOVIRICIDES, INC. (1)
NantKwest, Inc. (22)
Natera, Inc. (5)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (4)
NEUROCRINE BIOSCIENCES INC (5)
Neurotrope, Inc. (1)
NexImmune, Inc. (2)
NextCure, Inc. (4)
Nkarta, Inc. (11)
NORTHWEST BIOTHERAPEUTICS INC (4)
NOVAVAX INC (27)
Novus Therapeutics, Inc. (6)
NTN BUZZTIME INC (14)
Nurix Therapeutics, Inc. (6)
Ohr Pharmaceutical Inc (10)
Olivia Ventures, Inc. (1)
Omega Therapeutics, Inc. (5)
OncoCyte Corp (6)
Oncorus, Inc. (6)
ONCOSEC MEDICAL Inc (8)
OPGEN INC (10)
Ophthotech Corp. (7)
Opko Health, Inc. (2)
ORAGENICS INC (3)
Orchard Therapeutics plc (1)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (10)
ORGANOVO HOLDINGS, INC. (7)
Oric Pharmaceuticals, Inc. (2)
Outlook Therapeutics, Inc. (8)
Passage BIO, Inc. (4)
PDL BIOPHARMA, INC. (10)
Pfenex Inc. (4)
PhaseBio Pharmaceuticals Inc (1)
Phio Pharmaceuticals Corp. (4)
PIERIS PHARMACEUTICALS, INC. (6)
PLURISTEM THERAPEUTICS INC (1)
PMV Pharmaceuticals, Inc. (3)
POLARITYTE, INC. (7)
PORTOLA PHARMACEUTICALS INC (3)
Poseida Therapeutics, Inc. (4)
Praxis Precision Medicines, Inc. (3)
PRECISION BIOSCIENCES INC (10)
Prelude Therapeutics Inc (3)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (3)
Progenics Pharmaceuticals, Inc. (3)
Prometheus Biosciences, Inc. (2)
Protagenic Therapeutics, Inc. (2)
Protagonist Therapeutics, Inc (9)
Protalix BioTherapeutics, Inc. (2)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (10)
Prothena Corp plc (3)
PTC THERAPEUTICS, INC. (5)
PUMA BIOTECHNOLOGY, INC. (5)
Pyxis Oncology, Inc. (1)
Radius Health, Inc. (11)
RAPT Therapeutics, Inc. (4)
RECURSION PHARMACEUTICALS, INC. (10)
Regeneron Pharmaceuticals (18)
REGENXBIO Inc. (14)
Regulus Therapeutics Inc. (12)
Relay Therapeutics, Inc. (1)
Repare Therapeutics Inc. (11)
Replimune Group, Inc. (3)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (11)
REXAHN PHARMACEUTICALS, INC. (13)
Rezolute, Inc. (2)
RHYTHM PHARMACEUTICALS, INC. (4)
RIGEL PHARMACEUTICALS INC (8)
RITTER PHARMACEUTICALS INC (2)
ROCKET PHARMACEUTICALS, INC. (9)
Rubius Therapeutics, Inc. (2)
Sage Therapeutics, Inc. (10)
Sana Biotechnology, Inc. (2)
SANGAMO THERAPEUTICS, INC (11)
Sarepta Therapeutics, Inc. (12)
Savara Inc (6)
Scholar Rock Holding Corp (2)
SEATTLE GENETICS INC (8)
SELECTA BIOSCIENCES INC (8)
SELLAS Life Sciences Group, Inc. (8)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (4)
Seres Therapeutics, Inc. (5)
Sesen Bio, Inc. (3)
Shattuck Labs, Inc. (2)
Sierra Oncology, Inc. (6)
Sigilon Therapeutics, Inc. (5)
Silverback Therapeutics, Inc. (4)
SOLENO THERAPEUTICS INC (3)
Solid Biosciences Inc. (4)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (6)
Spectrum Pharmaceuticals, Inc. (8)
Spero Therapeutics, Inc. (3)
SPHERIX INC (1)
Spinning Eagle Acquisition Corp. (4)
Spring Bank Pharmaceuticals, Inc. (5)
SpringWorks Therapeutics, Inc. (1)
SPRUCE BIOSCIENCES, INC. (2)
SQZ Biotechnologies Co (1)
Stellar Biotechnologies, Inc. (7)
Stoke Therapeutics, Inc. (5)
Summit Therapeutics Inc. (2)
SUNESIS PHARMACEUTICALS INC (10)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (2)
SYNLOGIC, INC. (5)
Synthetic Biologics, Inc. (2)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (10)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (2)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (2)
Tenaya Therapeutics, Inc. (3)
Tocagen Inc (6)
Tonix Pharmaceuticals Holding Corp. (3)
Tracon Pharmaceuticals, Inc. (2)
Translate Bio, Inc. (1)
TREVENA INC (8)
Trovagene, Inc. (5)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (7)
Twist Bioscience Corp (12)
Tyra Biosciences, Inc. (4)
U.S. Stem Cell, Inc. (5)
Ultragenyx Pharmaceutical Inc. (18)
uniQure N.V. (5)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (4)
UroGen Pharma Ltd. (2)
Vanda Pharmaceuticals Inc. (11)
Vaxart, Inc. (5)
Vaxcyte, Inc. (6)
VBI Vaccines Inc (16)
VERACYTE, INC. (5)
Verastem, Inc. (3)
Vericel Corp (4)
Vertex Pharmaceuticals Inc (7)
Verve Therapeutics, Inc. (4)
VICAL INC (4)
Viela Bio, Inc. (1)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (4)
Vir Biotechnology, Inc. (2)
VistaGen Therapeutics, Inc. (3)
VITAL THERAPIES INC (4)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (3)
Voyager Therapeutics, Inc. (10)
Werewolf Therapeutics, Inc. (3)
WINDTREE THERAPEUTICS INC (8)
XBiotech Inc. (4)
Xencor Inc (10)
Xenetic Biosciences, Inc. (2)
Xenon Pharmaceuticals Inc. (5)
Xilio Therapeutics, Inc. (1)
XOMA Corp (10)
Y-mAbs Therapeutics, Inc. (1)
YIELD10 BIOSCIENCE, INC. (7)
ZAFGEN, INC. (8)
Zai Lab Ltd (1)
Zentalis Pharmaceuticals, LLC (10)
ZIOPHARM ONCOLOGY INC (5)
Zymeworks Inc. (2)

Recent Contracts

Office Lease Agreement by and between the Registrant and OC 990 Corporate Center Associates, LLC dated July 22, 2024 (KalVista Pharmaceuticals, Inc., Filed With SEC on September 5, 2024)
Landlord Consent to Assignment and Assumption of Lease dated February 1, 2024 by and among Presidio Trust, Kinnate Biopharma Inc., and Eventbrite, Inc (XOMA Corp, Filed With SEC on August 13, 2024)
Net Office Lease dated August 5, 2021 between Presidio Trust and Kinnate Biopharma Inc (XOMA Corp, Filed With SEC on August 13, 2024)
Sublease Agreement by and between the Company and GeneFab (Dynamics Special Purpose Corp., Filed With SEC on August 13, 2024)
Second Amendment to Office Building Net Lease Agreement effective as of May 10, 2024 (Gritstone Oncology, Inc., Filed With SEC on August 13, 2024)
First Amendment to Office Building Lease, dated September 30, 2020, by and between The Strafford Office Buildings and Palvella Therapeutics, Inc (PIERIS PHARMACEUTICALS, INC., Filed With SEC on August 9, 2024)
Office Building Lease, dated May 18, 2018, by and between The Strafford Office Buildings and Palvella Therapeutics, Inc (PIERIS PHARMACEUTICALS, INC., Filed With SEC on August 9, 2024)
First Amendment to Lease between HCP Oyster Point III LLC and the Registrant dated as of September 6, 2016 (Tenaya Therapeutics, Inc., Filed With SEC on August 8, 2024)
SECOND AMENDMENT TO LEASE AGREEMENT (Suite 270) (IN8BIO, INC., Filed With SEC on August 8, 2024)
SECOND AMENDMENT TO LEASE AGREEMENT (Suite 230) (IN8BIO, INC., Filed With SEC on August 8, 2024)
First Amendment to Lease Agreement, dated May 13, 2024, by and between Scholar Rock, Inc. and BMR-Rogers Street LLC (Scholar Rock Holding Corp, Filed With SEC on August 8, 2024)
Lease Termination Agreement, dated August 5, 2024, by and between BMR-One Research Way LLC and PMV Pharmaceuticals, Inc (PMV Pharmaceuticals, Inc., Filed With SEC on August 8, 2024)
Fourth Amendment to Lease by and between Registrant and Watch City Ventures MT, LLC dated as of April 8, 2024 (MIRAGEN THERAPEUTICS, INC., Filed With SEC on August 8, 2024)
Lease Termination Agreement by and between BMR-Rogers Street LLC and Synlogic, Inc (SYNLOGIC, INC., Filed With SEC on August 8, 2024)
Sixth Amendment, dated as of July 12, 2024, to Lease by and between HCP LS Redwood City, LLC and Revolution Medicines, Inc (Revolution Medicines, Inc., Filed With SEC on August 7, 2024)
Third Amendment to Lease Agreement, dated July 31, 2024 between Omega Therapeutics, Inc. and ARE-MA Region No. 94, LLC (Omega Therapeutics, Inc., Filed With SEC on August 6, 2024)
Second Amendment to Lease Agreement, dated June 24, 2024 between Omega Therapeutics, Inc. and ARE-MA Region No. 94, LLC (Omega Therapeutics, Inc., Filed With SEC on August 6, 2024)
Third Amendment to Lease dated March 6, 2017 by and between Protagonist Therapeutics, Inc., as Tenant, and BMR-Pacific Research Center, LP as Landlord, dated May 6, 2024 (Protagonist Therapeutics, Inc, Filed With SEC on August 6, 2024)
Second Amendment dated as of June 11, 2024 to the Amended and Restated Lease Agreement dated as of August 21, 2023 by and between the Registrant and Lots 21 and 22 Owner (DE) LLC,... (IONIS PHARMACEUTICALS INC, Filed With SEC on August 1, 2024)
Assignment and Assumption of Lease, dated July 22, 2024, by and between uniQure, Inc. and Genezen MA, Inc (uniQure N.V., Filed With SEC on August 1, 2024)
Landlord Consent to Assignment and Assumption of Lease and Third Amendment to Lease, dated June 28, 2024, by and among Hartwell Innovation Campus, LLC, uniQure, Inc. and Genezen... (uniQure N.V., Filed With SEC on August 1, 2024)
Fifth Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of April 29, 2024 (Aldeyra Therapeutics, Inc., Filed With SEC on August 1, 2024)
Lease Amendment, dated September 14, 2023, by and between LSREF4 Turtle, LLC and Celularity Inc (GX Acquisition Corp., Filed With SEC on July 30, 2024)
Office Lease, dated June 12, 2019, by and between the Registrant and AAT La Jolla Commons, LLC (as successor-in-interest to HSPFLa Jolla Commons I Investors LLC) (Artiva Biotherapeutics, Inc., Filed With SEC on June 28, 2024)
Sublease Termination Agreement, dated June 5, 2024, by and between AlloVir, Inc. and AMAG Pharmaceuticals, Inc (Allovir, Inc., Filed With SEC on June 11, 2024)
Lease Amendment, dated January 2, 2024, by and between the Registrant and PDM 930 Unit, LLC (Aerovate Therapeutics, Inc., Filed With SEC on May 13, 2024)
Second Amendment to Lease Agreement between the registrant and Hartco Ventura Inc. dated January 1, 2024 (Avita Therapeutics, Inc., Filed With SEC on May 13, 2024)
Fourth Amendment to Lease by and between Bulfinch Square Limited Partnership and Leap Therapeutics, Inc. dated as of January 3, 2024 (LEAP THERAPEUTICS, INC., Filed With SEC on May 13, 2024)
Second Amendment to Lease Agreement between the Company (Suite 270) and Sloss Martin Biscuit, Ltd., dated March 16, 2024 (IN8BIO, INC., Filed With SEC on May 9, 2024)
Second Amendment to Lease Agreement between the Company (Suite 230) and Sloss Martin Biscuit, Ltd., dated March 16, 2024 (IN8BIO, INC., Filed With SEC on May 9, 2024)
Lease Agreement (Suite 210) between the Company and Sloss Martin Biscuit, Ltd., dated March 16, 2024 (IN8BIO, INC., Filed With SEC on May 9, 2024)
Third Amendment to Lease, dated January 26, 2024, by and between the Company and AG-LC 465 North Halstead Owner, L.P (Xencor Inc, Filed With SEC on May 9, 2024)
Sublease Agreement, dated April 19, 2024, by and between Surrozen (Consonance-HFW Acquisition Corp., Filed With SEC on May 8, 2024)
First Amendment to Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated May 7, 2024 (SELECTA BIOSCIENCES INC, Filed With SEC on May 8, 2024)
Sublease, dated March 7, 2024, by and between Company and Metagenomi, Inc (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on May 8, 2024)
Third Amendment to Lease, dated May 2, 2024, by and between the Registrant and 500 Boylston & 222 Berkeley Owner (DE) LLC (RHYTHM PHARMACEUTICALS, INC., Filed With SEC on May 7, 2024)
First Amendment to Lease Agreement, dated March 26, 2024 by and between the Registrant and ACA Concourse East Unit 3 LLC (CASTLE BIOSCIENCES INC, Filed With SEC on May 2, 2024)
Amendment Number 3 to Lease Agreement by and between Ardelyx, Inc, and Prospect Fifth Avenue, LLC (ARDELYX, INC., Filed With SEC on May 2, 2024)
Amendment Number 2 to Lease Agreement by and between Ardelyx, Inc, and Prospect Fifth Avenue, LLC (ARDELYX, INC., Filed With SEC on May 2, 2024)
First Amendment to Lease by and between the Registrant and San Diego Creekside, LLC, dated April 8, 2024 (aTYR PHARMA INC, Filed With SEC on May 2, 2024)